Skip to main content
TraumaDrugPhase 2

What this study is

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

What's being tested

  • Calcium Gluconate

    Intervention · DRUG

    1 gram calcium gluconate provided via intravenous or intraosseous access over approximately 2-5 minutes

  • Vasopressin

    Intervention · DRUG

    4 unit vasopressin bolus followed by vasopressin infusion at 0.04 U/min for eight hours

  • saline placebo

    Intervention · DRUG

    saline placebo volume matched to prehospital or in hospital phase

Study details

Sponsor
Jason Sperry
Conditions
Trauma · Hemorrhage
Enrolling
1,050 people
Starts
2024-06-30
Est. completion
2028-03
Design
Quadruple-blind, randomized, sequential groups, Phase 2
Record
View on ClinicalTrials.gov ↗